Diary - News
All news Erytech announces clinical results
ERYTECH Pharma (Euronext Paris: ERYP),the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, announces the publication of two peer-reviewed manuscripts describing clinical results obtained with ERY-ASP/GRASPA®.
Read the press release
